Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-11,008
Closed -$2.11M – 465
2022
Q1
$2.11M Sell
11,008
-431
-4% -$87.4K 0.02% 553
2021
Q4
$2.7M Sell
11,439
-240
-2% -$54.5K 0.02% 510
2021
Q3
$2.42M Sell
11,679
-335
-3% -$74.4K 0.02% 506
2021
Q2
$2.64M Sell
12,014
-671
-5% -$148K 0.02% 493
2021
Q1
$2.65M Sell
12,685
-77
-0.6% -$15.3K 0.02% 653
2020
Q4
$2.54M Sell
12,762
-71
-0.6% -$13.5K 0.02% 749
2020
Q3
$2.34M Buy
12,833
+717
+6% +$124K 0.02% 721
2020
Q2
$1.92M Buy
12,116
+416
+4% +$63.6K 0.02% 777
2020
Q1
$1.62M Sell
11,700
-57
-0.5% -$8.94K 0.01% 761
2019
Q4
$2.02M Sell
11,757
-827
-7% -$134K 0.01% 868
2019
Q3
$2.06M Buy
+12,584
New +$2.09M 0.01% 888

Other funds holding IEX

Mackay Shields LLC's IEX Position: Q2 2022 in Review

Mackay Shields LLC sold out of IDEX (IEX) in Q2 2022, closing a stake of 11,008 shares — an estimated $2.11M sold.

Mackay Shields LLC first reported a position in IEX in Q3 2019 and held it in 11 quarters. The position peaked at $2.7M in Q4 2021. 567 funds tracked by Wall St. Rank hold IEX as of Q2 2022.

  • Mackay Shields LLC reported no remaining IDEX position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 11,008 IDEX shares in Q2 2022, an estimated $2.11M.
  • Mackay Shields LLC first reported a position in IDEX in Q3 2019 and held it in 11 quarters.
  • Mackay Shields LLC's IDEX position peaked at $2.7M in Q4 2021.
  • 567 funds tracked by Wall St. Rank held IDEX as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.